I think it's very interesting; he dumped BAC, his #1 or #2 position, and went massively after BRK and Cimpress (which was hammered in August) and to a less degree DNOW (which he sold down a bit in Q2) and MSM. Cimpress has already payed of handsomely, while BAC has beformed better than BRK. MSC hasn't been good, but DNOW probably has depending on when exactly he bought it. I like this guy and his picks (and started cloning him earlier this year).